Similarly, tumor‐derived exosomal EGFR and phospho‐EGFR fall during anti‐EGFR (cetuximab) therapy, suggesting EV‐EGFR can monitor therapeutic response (63). The gene discussed is EGFR; the disease is neoplasm.